Pharvaris CFO sells 10,000 company shares

Rhea-AI Filing Summary

Pharvaris N.V. CFO/CLO David W. Nassif reported an open-market sale of 10,000 shares of Common Stock at a weighted average price of $30.3076 per share. The shares sold were previously acquired upon vesting of restricted stock units. Following this transaction, he directly holds 120,300 shares. The filing also corrects a prior Form 3 that understated his beneficial ownership by 6,375 shares due to an administrative error in tax-withholding reporting.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Nassif David W.

Role CFO / CLO

Sold 10,000 shs ($303K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$30.3076	$303K

Holdings After Transaction: Common Stock — 120,300 shares (Direct)

Footnotes (2)

1. F1. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.55 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. F2. The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 6,375 shares due to an administrative error in the number of shares reported as withheld for tax obligations in connection with an RSU vesting transaction. This filing reflects the corrected beneficial ownership amount.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $30.3076 per share Price range: $30.08–$30.55 per share +2 more

5 metrics

Shares sold 10,000 shares Open-market sale on May 21, 2026

Weighted average sale price $30.3076 per share Common Stock sale on May 21, 2026

Price range $30.08–$30.55 per share Range of executed sale prices

Shares owned after transaction 120,300 shares Direct holdings following reported sale

Prior ownership understatement 6,375 shares Correction of previously reported beneficial ownership

Key Terms

weighted average sale price, restricted stock units, beneficially owned, withheld for tax obligations

4 terms

weighted average sale price financial

"The reported price represents a weighted average sale price for shares sold in multiple transactions"

restricted stock units financial

"The shares sold were acquired upon vesting of restricted stock units on various dates"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

beneficially owned financial

"The total number of shares beneficially owned previously reported in the Form 3"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

withheld for tax obligations financial

"shares reported as withheld for tax obligations in connection with an RSU vesting transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pharvaris (PHVS) report for David W. Nassif?

Pharvaris reported that CFO/CLO David W. Nassif sold 10,000 shares of Common Stock in an open-market transaction at a weighted average price of $30.3076 per share. These shares came from vested restricted stock units, reflecting a routine disposition rather than a new grant.

At what price did the Pharvaris (PHVS) insider sale occur?

The reported sale used a weighted average price of $30.3076 per share, covering multiple trades between $30.08 and $30.55. This range reflects normal market execution across several transactions on the same date, summarized as one line in the Form 4 filing.

How many Pharvaris (PHVS) shares does David W. Nassif hold after the sale?

After selling 10,000 shares, David W. Nassif directly holds 120,300 shares of Pharvaris Common Stock. This remaining position, disclosed in the Form 4, shows he continues to own a substantial stake even after the open-market sale linked to vested restricted stock units.

Were the Pharvaris (PHVS) shares sold newly purchased or from equity awards?

The 10,000 shares sold were acquired upon vesting of restricted stock units on various dates, not from a new market purchase. This indicates the transaction is related to equity compensation, a common practice for executives managing tax or liquidity needs.

Did Pharvaris (PHVS) correct any prior ownership reporting in this Form 4?

Yes. The Form 4 explains that a prior Form 3 filed March 18, 2026 understated Nassif’s beneficial ownership by 6,375 shares. The error stemmed from misreporting shares withheld for tax obligations on an RSU vesting, and the current filing reflects the corrected amount.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 05:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nassif David W.

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

LEXINGTON

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO / CLO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		S		10,000	D	$30.3076(1)	120,300(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.55 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

2. The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 6,375 shares due to an administrative error in the number of shares reported as withheld for tax obligations in connection with an RSU vesting transaction. This filing reflects the corrected beneficial ownership amount.

	/s/ Marnus Nel, Attorney-in-Fact for David W. Nassif	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)